James H. Sabry, Director at CYTOKINETICS INC (CYTK), sold 48,906 shares at $3.16 ($153K) on 2009-12-02, disclosed to the SEC on 2009-12-04.
Open-market sale of $153k CYTK by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.11 | 33 | $103 | 0.1% |
| 2 | $3.12 | 11,436 | $36K | 23.3% |
| 3 | $3.13 | 22,538 | $71K | 46.1% |
| 4 | $3.14 | 9,899 | $31K | 20.3% |
| 5 | $3.14 | 200 | $628 | 0.4% |
| 6 | $3.14 | 600 |
| $2K |
| 1.2% |
| 7 | $3.15 | 2,400 | $8K | 4.9% |
| 8 | $3.15 | 300 | $945 | 0.6% |
| 9 | $3.16 | 100 | $316 | 0.2% |
| 10 | $3.16 | 700 | $2K | 1.4% |
| 11 | $3.17 | 500 | $2K | 1.0% |
| 12 | $3.17 | 200 | $634 | 0.4% |
| Total | $3.13 avg | 48,906 | $153K | 100% |
| Filing → |
| CYTK | SELL | 2010-05-14 | $30K | — | Filing → |
| CYTK | SELL | 2010-04-28 | $32K | — | Filing → |
| CYTK | SELL | 2010-04-01 | $32K | — | Filing → |